Income Statement Takara Holdings Inc.

Equities

2531

JP3459600007

Distillers & Wineries

Market Closed - Japan Exchange Other stock markets 06:30:00 16/01/2026 GMT			5-day change	1st Jan Change
1,656.00 ^JPY	-0.99%		+1.85%	+3.05%

01-06	Takara Holdings Inc. announces Annual dividend, payable on June 30, 2026	CI
12-18	Valueact Funds raise stake in Takara Holdings to 12.44% from 9.84%, filing shows	RE

bca8c00c0a5bfb368294b18a085.OmGT4YaygH3vTs4txo45cNj56J5QxiztdKA6AqHx4Zs.fTOk0cWB5iyMCrRU8v0ORZ--kOo9g2WhFsV-SuTFmPxjU8LV_t3JE4oDuQ

Published financial data: TAKARA HOLDINGS INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	278B	301B	351B	339B	363B
Total Revenues	278B	301B	351B	339B	363B
Cost of Goods Sold, Total	163B	187B	231B	225B	243B
Gross Profit	116B	114B	120B	114B	120B
Selling General & Admin Expenses, Total	83.72B	61.16B	70.12B	79.42B	87.43B
R&D Expenses	5.91B	6.48B	8.95B	8.72B	7.31B
Depreciation & Amortization - (IS)	2.31B	2.54B	2.92B	3.54B	4.31B
Other Operating Expenses	2.05B	-	-	-	-
Other Operating Expenses, Total	94B	70.19B	82B	91.69B	99.05B
Operating Income	21.6B	43.36B	37.95B	22.24B	20.6B
Interest Expense, Total	-344M	-330M	-324M	-450M	-700M
Interest And Investment Income	707M	766M	1.06B	1.4B	1.93B
Net Interest Expenses	363M	436M	741M	955M	1.23B
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-	-807M	-222M	-	-
Other Non Operating Income (Expenses)	97M	246M	238M	137M	354M
EBT, Excl. Unusual Items	22.06B	43.23B	38.7B	23.34B	22.18B
Gain (Loss) On Sale Of Investments	2M	-	674M	3.97B	3.7B
Gain (Loss) On Sale Of Assets	-422M	-	-235M	-842M	287M
Asset Writedown	-949M	-4.47B	-	-207M	-377M
Other Unusual Items	-104M	2.2B	548M	-20M	29M
EBT, Incl. Unusual Items	20.58B	40.96B	39.69B	26.24B	25.81B
Income Tax Expense	6.33B	11.59B	11B	8.47B	8.49B
Earnings From Continuing Operations	14.26B	29.37B	28.69B	17.76B	17.32B
Net Income to Company	14.26B	29.37B	28.69B	17.76B	17.32B
Minority Interest	-3.68B	-8.6B	-7.48B	-1.59B	-1.12B
Net Income - (IS)	10.57B	20.77B	21.21B	16.18B	16.2B
Net Income to Common Incl Extra Items	10.57B	20.77B	21.21B	16.18B	16.2B
Net Income to Common Excl. Extra Items	10.57B	20.77B	21.21B	16.18B	16.2B
Per Share Items
Net EPS - Basic	53.48	105.05	107.26	82.09	82.98
Basic EPS - Continuing Operations	53.48	105.05	107.26	82.09	82.98
Basic Weighted Average Shares Outstanding	198M	198M	198M	197M	195M
Net EPS - Diluted	53.48	105.05	107.26	82.09	82.98
Diluted EPS - Continuing Operations	53.48	105.05	107.26	82.09	82.98
Diluted Weighted Average Shares Outstanding	198M	198M	198M	197M	195M
Normalized Basic EPS	51.1	93.16	84.5	65.95	65.26
Normalized Diluted EPS	51.1	93.16	84.5	65.95	65.26
Dividend Per Share	21	37	38	29	31
Payout Ratio	37.37	19.97	34.45	46.38	34.93
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	30.53B	52.66B	48.06B	33.42B	32.67B
EBITA	22.46B	44.23B	38.94B	23.42B	22.32B
EBIT	21.6B	43.36B	37.95B	22.24B	20.6B
Effective Tax Rate - (Ratio)	30.74	28.3	27.72	32.29	32.9
Normalized Net Income	10.1B	18.42B	16.71B	13B	12.74B
Non-Cash Pension Expense	-6M	272M	223M	258M	255M
Supplemental Operating Expense Items
Advertising Expense	34.33B	6.39B	7.06B	9.14B	8.15B
Selling and Marketing Expenses	43.22B	16.39B	18.18B	20.5B	20.32B
Research And Development Expense From Footnotes	5.91B	6.48B	8.95B	8.72B	7.31B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	66.24B	80.44B	96.82B	95.08B	83.3B
Short Term Investments	1.14B	1.18B	-	-	-
Total Cash And Short Term Investments	67.38B	81.62B	96.82B	95.08B	83.3B
Accounts Receivable, Total	61.44B	69.81B	69.02B	69.3B	72.58B
Total Receivables	61.44B	69.81B	69.02B	69.3B	72.58B
Inventory	49.12B	72.64B	66.9B	71.05B	82.33B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	5.16B	8.25B	8.77B	9.77B	7.22B
Total Current Assets	183B	232B	242B	245B	245B
Net Property Plant And Equipment	74.74B	79.75B	88.89B	105B	124B
Long-term Investments	31.09B	32.32B	50.67B	67.12B	64.75B
Goodwill	10.14B	10.07B	10.67B	12.15B	25.28B
Other Intangibles, Total	5.75B	5.29B	5.26B	6.18B	16.38B
Deferred Tax Assets Long-Term	2.09B	2.68B	2.17B	1.91B	2.13B
Other Long-Term Assets, Total	1M	2M	2M	1M	2M
Total Assets	307B	362B	399B	437B	478B
Liabilities
Accounts Payable, Total	16.48B	20.97B	21.78B	22.32B	24.07B
Accrued Expenses, Total	9.18B	8.74B	9.75B	12.3B	3.44B
Short-term Borrowings	5.17B	5.5B	4.92B	10.01B	12.32B
Current Portion of Long-Term Debt	-	10B	-	5B	-
Current Income Taxes Payable	10.91B	13.77B	8.04B	10.77B	2.74B
Other Current Liabilities	14.53B	20.17B	22.98B	20.26B	30.86B
Total Current Liabilities	56.27B	79.15B	67.45B	80.66B	73.42B
Long-Term Debt	35.46B	35.25B	35.19B	25.42B	45.69B
Long-Term Leases	3.12B	3B	4.45B	7.37B	7.6B
Pension & Other Post Retirement Benefits	9.27B	8.94B	8.92B	8.74B	8.34B
Deferred Tax Liability Non Current	3.83B	3.97B	4.86B	8.81B	9.28B
Other Non Current Liabilities	7.42B	7.57B	22.98B	26.02B	32.36B
Total Liabilities	115B	138B	144B	157B	177B
Common Stock, Total	13.23B	13.23B	13.23B	13.23B	13.23B
Additional Paid In Capital	2.29B	2.5B	1.99B	2.72B	2.8B
Retained Earnings	135B	150B	164B	170B	180B
Treasury Stock	-1.68B	-1.68B	-1.68B	-2.1B	-2.1B
Comprehensive Income and Other	7.86B	16.44B	26.59B	44.92B	50.85B
Total Common Equity	157B	180B	204B	229B	245B
Minority Interest	34.65B	44.14B	51.37B	51.8B	55.68B
Total Equity	192B	225B	255B	280B	301B
Total Liabilities And Equity	307B	362B	399B	437B	478B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	198M	198M	198M	195M	195M
ECS Total Common Shares Outstanding	198M	198M	198M	195M	195M
Book Value / Share	793.52	912.57	1.03K	1.17K	1.26K
Tangible Book Value	141B	165B	188B	210B	204B
Tangible Book Value Per Share	713.16	834.88	951.02	1.08K	1.04K
Total Debt	43.75B	53.75B	44.56B	47.8B	65.6B
Net Debt	-23.63B	-27.87B	-52.26B	-47.29B	-17.7B
Debt Equivalent of Unfunded Proj. Benefit Obligation	8.38B	8.04B	7.87B	7.22B	6.79B
Minority Interest, Total (Incl. Fin. Div)	34.65B	44.14B	51.37B	51.8B	55.68B
Inventories - Raw Materials, Total	6.08B	7.46B	7.37B	7.56B	7.81B
Inventories - Work In Process, Total	1.92B	2.01B	1.72B	1.66B	1.73B
Inventories - Finished Goods, Total	41.12B	63.17B	57.81B	61.83B	72.8B
Full Time Employees	4.75K	4.93K	5.17K	5.49K	5.73K
Accumulated Allowance for Doubtful Accounts (Supple)	516M	449M	694M	817M	739M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	20.58B	40.96B	39.69B	26.24B	25.82B
Depreciation & Amortization - CF	8.07B	8.42B	9.12B	10B	10.35B
Amortization of Goodwill and Intangible Assets - (CF)	865M	875M	998M	1.18B	1.73B
Depreciation & Amortization, Total	8.93B	9.3B	10.12B	11.18B	12.07B
(Gain) Loss From Sale Of Asset	723M	504M	235M	1B	91M
(Gain) Loss on Sale of Investments - (CF)	-	-	-674M	-3.97B	-3.7B
Other Operating Activities, Total	-4.61B	-9.57B	-14.88B	-8.92B	-6.8B
Change In Accounts Receivable	-1.16B	-7.11B	2.63B	1.99B	714M
Change In Inventories	-691M	-21.24B	8.97B	982M	-5.02B
Change In Accounts Payable	963M	2.31B	494M	-1.59B	-2.52B
Change in Other Net Operating Assets	2.36B	1.21B	-1.1B	2.26B	-4.49B
Cash from Operations	27.1B	16.38B	45.48B	29.18B	16.16B
Capital Expenditure	-13.91B	-14.76B	-10.62B	-19.21B	-20.14B
Sale of Property, Plant, and Equipment	-	1.33B	430M	-	765M
Cash Acquisitions	-	-	-1.07B	-5.44B	-23.84B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	5.55B	-755M	1.12B	5.81B	2.13B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	1.63B	3.79B	-335M	-1.15B	-473M
Cash from Investing	-6.74B	-10.4B	-10.47B	-19.99B	-41.56B
Short Term Debt Issued, Total	5B	-	-	-	-
Long-Term Debt Issued, Total	10.07B	9.93B	-	466M	25.1B
Total Debt Issued	15.07B	9.93B	-	466M	25.1B
Short Term Debt Repaid, Total	-5B	-	-435M	-262M	-46M
Long-Term Debt Repaid, Total	-5.06B	-	-10.36B	-105M	-10.8B
Total Debt Repaid	-10.06B	-	-10.8B	-367M	-10.85B
Repurchase of Common Stock	-	-	-	-3B	-
Common Dividends Paid	-3.95B	-4.15B	-7.3B	-7.5B	-5.66B
Common & Preferred Stock Dividends Paid	-3.95B	-4.15B	-7.3B	-7.5B	-5.66B
Other Financing Activities, Total	-2.56B	-1.65B	-4.11B	-3.04B	-2.05B
Cash from Financing	-1.51B	4.13B	-22.22B	-13.45B	6.55B
Foreign Exchange Rate Adjustments	-536M	2.76B	3.27B	2.66B	3.95B
Miscellaneous Cash Flow Adjustments	-1M	1M	-	1M	1M
Net Change in Cash	18.32B	12.87B	16.06B	-1.6B	-14.9B
Supplemental Items
Cash Interest Paid	364M	334M	340M	457M	736M
Cash Income Tax Paid (Refund)	4.77B	10.25B	15.54B	8.46B	6.77B
Levered Free Cash Flow	12.21B	-994M	27.9B	3.27B	-12.18B
Unlevered Free Cash Flow	12.42B	-788M	28.1B	3.55B	-11.74B
Change In Net Working Capital	-3.9B	22.42B	-4.89B	2.32B	16.55B
Net Debt Issued / Repaid	5.01B	9.93B	-10.8B	99M	14.25B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	4.57	8.1	6.23	3.32	2.81
Return on Total Capital	5.93	10.55	8.2	4.43	3.71
Return On Equity %	7.65	14.12	11.96	6.63	5.96
Return on Common Equity	6.94	12.31	11.03	7.48	6.84
Margin Analysis
Gross Profit Margin %	41.51	37.73	34.2	33.57	32.99
SG&A Margin	30.07	20.32	20	23.4	24.1
EBITDA Margin %	10.96	17.5	13.71	9.85	9.01
EBITA Margin %	8.07	14.7	11.11	6.9	6.16
EBIT Margin %	7.76	14.41	10.82	6.55	5.68
Income From Continuing Operations Margin %	5.12	9.76	8.18	5.23	4.78
Net Income Margin %	3.8	6.9	6.05	4.77	4.47
Net Avail. For Common Margin %	3.8	6.9	6.05	4.77	4.47
Normalized Net Income Margin	3.63	6.12	4.76	3.83	3.51
Levered Free Cash Flow Margin	4.38	-0.33	7.96	0.96	-3.36
Unlevered Free Cash Flow Margin	4.46	-0.26	8.01	1.05	-3.24
Asset Turnover
Asset Turnover	0.94	0.9	0.92	0.81	0.79
Fixed Assets Turnover	3.85	3.9	4.16	3.5	3.17
Receivables Turnover (Average Receivables)	4.56	4.59	5.05	4.91	5.11
Inventory Turnover (Average Inventory)	3.32	3.08	3.31	3.27	3.17
Short Term Liquidity
Current Ratio	3.25	2.94	3.58	3.04	3.34
Quick Ratio	2.29	1.91	2.46	2.04	2.12
Operating Cash Flow to Current Liabilities	0.48	0.21	0.67	0.36	0.22
Days Sales Outstanding (Average Receivables)	80.06	79.6	72.25	74.59	71.39
Days Outstanding Inventory (Average Inventory)	109.94	118.6	110.38	111.98	115.17
Average Days Payable Outstanding	36.86	32.41	34.68	35.14	33.28
Cash Conversion Cycle (Average Days)	153.14	165.78	147.96	151.43	153.28
Long Term Solvency
Total Debt/Equity	22.84	23.94	17.45	17.04	21.8
Total Debt / Total Capital	18.6	19.31	14.86	14.56	17.9
LT Debt/Equity	20.15	17.04	15.52	11.69	17.71
Long-Term Debt / Total Capital	16.4	13.74	13.22	9.99	14.54
Total Liabilities / Total Assets	37.59	38.04	36.04	35.89	37
EBIT / Interest Expense	62.78	131.38	117.12	49.43	29.43
EBITDA / Interest Expense	88.74	159.56	148.34	74.27	46.67
(EBITDA - Capex) / Interest Expense	48.31	114.83	115.57	31.58	17.9
Total Debt / EBITDA	1.43	1.02	0.93	1.43	2.01
Net Debt / EBITDA	-0.77	-0.53	-1.09	-1.41	-0.54
Total Debt / (EBITDA - Capex)	2.63	1.42	1.19	3.36	5.24
Net Debt / (EBITDA - Capex)	-1.42	-0.74	-1.4	-3.33	-1.41
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.98	8.07	16.53	-3.22	6.87
Gross Profit, 1 Yr. Growth %	6.42	-1.78	5.64	-5.01	5.02
EBITDA, 1 Yr. Growth %	25.58	72.48	-8.72	-30.46	-2.24
EBITA, 1 Yr. Growth %	34.63	96.93	-11.95	-39.86	-4.68
EBIT, 1 Yr. Growth %	36.37	100.76	-12.48	-41.38	-7.4
Earnings From Cont. Operations, 1 Yr. Growth %	33.36	106.02	-2.32	-38.08	-2.49
Net Income, 1 Yr. Growth %	17.75	96.42	2.1	-23.72	0.16
Normalized Net Income, 1 Yr. Growth %	19.45	82.31	-9.29	-22.21	-1.95
Diluted EPS Before Extra, 1 Yr. Growth %	18.56	96.42	2.1	-23.47	1.08
Accounts Receivable, 1 Yr. Growth %	1.2	13.63	-1.13	0.41	4.72
Inventory, 1 Yr. Growth %	0.3	47.88	-7.9	6.2	15.88
Net Property, Plant and Equip., 1 Yr. Growth %	7.02	6.7	11.46	17.99	17.86
Total Assets, 1 Yr. Growth %	8.11	18.09	10.14	9.59	9.17
Tangible Book Value, 1 Yr. Growth %	9.25	17.07	13.91	11.86	-3.22
Common Equity, 1 Yr. Growth %	6.17	15	13.04	12.12	7.24
Cash From Operations, 1 Yr. Growth %	130.76	-39.57	177.71	-35.84	-44.63
Capital Expenditures, 1 Yr. Growth %	14.77	6.12	-28.07	80.92	4.86
Levered Free Cash Flow, 1 Yr. Growth %	-1.48K	-108.15	-2.91K	-88.29	-472.77
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.07K	-106.35	-3.67K	-87.37	-430.9
Dividend Per Share, 1 Yr. Growth %	5	76.19	2.7	-23.68	6.9
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.18	3.45	12.22	6.2	1.7
Gross Profit, 2 Yr. CAGR %	3.1	2.24	1.86	0.17	-0.12
EBITDA, 2 Yr. CAGR %	10.15	47.18	25.47	-20.33	-17.55
EBITA, 2 Yr. CAGR %	9.68	62.83	31.68	-27.23	-24.29
EBIT, 2 Yr. CAGR %	10.13	65.46	32.56	-28.37	-26.32
Earnings From Cont. Operations, 2 Yr. CAGR %	7.45	65.75	41.86	-22.23	-22.3
Net Income, 2 Yr. CAGR %	0.78	52.08	41.62	-11.75	-12.59
Normalized Net Income, 2 Yr. CAGR %	2.92	47.57	28.6	-16	-12.67
Diluted EPS Before Extra, 2 Yr. CAGR %	1.27	52.6	41.62	-11.6	-12.05
Accounts Receivable, 2 Yr. CAGR %	1.65	7.23	5.99	-0.36	2.54
Inventory, 2 Yr. CAGR %	3.3	21.79	16.7	-1.1	10.93
Net Property, Plant and Equip., 2 Yr. CAGR %	11.08	6.86	9.06	14.68	17.92
Total Assets, 2 Yr. CAGR %	3.39	12.99	14.04	9.86	9.38
Tangible Book Value, 2 Yr. CAGR %	4.84	13.09	15.48	12.88	4.05
Common Equity, 2 Yr. CAGR %	2.89	10.5	14.02	12.58	9.65
Cash From Operations, 2 Yr. CAGR %	41.64	18.09	29.54	33.48	-40.4
Capital Expenditures, 2 Yr. CAGR %	14.18	10.36	-12.63	14.08	37.73
Levered Free Cash Flow, 2 Yr. CAGR %	68.27	6.22	51.18	81.28	-33.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	65.18	11.89	50.41	112.2	-35.36
Dividend Per Share, 2 Yr. CAGR %	8.01	36.01	34.52	-11.47	-9.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.26	2.74	7.64	6.82	6.42
Gross Profit, 3 Yr. CAGR %	3.38	1.45	3.36	-0.48	1.76
EBITDA, 3 Yr. CAGR %	10.08	27.91	25.51	3.06	-14.71
EBITA, 3 Yr. CAGR %	10.92	33.31	32.65	1.41	-20.38
EBIT, 3 Yr. CAGR %	11.42	34.54	33.82	0.99	-21.97
Earnings From Cont. Operations, 3 Yr. CAGR %	4.4	33.49	38.97	7.61	-16.14
Net Income, 3 Yr. CAGR %	-1.39	25.89	33.17	15.22	-7.94
Normalized Net Income, 3 Yr. CAGR %	5.71	24.53	25.47	8.76	-11.56
Diluted EPS Before Extra, 3 Yr. CAGR %	-0.91	26.29	33.47	15.35	-7.56
Accounts Receivable, 3 Yr. CAGR %	2.2	5.49	4.37	4.1	1.3
Inventory, 3 Yr. CAGR %	4.61	16.42	10.96	13.09	4.26
Net Property, Plant and Equip., 3 Yr. CAGR %	9.14	9.6	8.37	11.96	15.73
Total Assets, 3 Yr. CAGR %	2.25	8.08	12.03	12.54	9.63
Tangible Book Value, 3 Yr. CAGR %	4.7	8.77	13.36	14.26	7.24
Common Equity, 3 Yr. CAGR %	2.63	6.78	11.34	13.38	10.77
Cash From Operations, 3 Yr. CAGR %	18.55	6.63	57.03	2.49	-0.45
Capital Expenditures, 3 Yr. CAGR %	28.21	11.42	-4.32	11.36	10.92
Levered Free Cash Flow, 3 Yr. CAGR %	15.5	-38.67	216.33	-35.55	130.52
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.17	-44.27	254.74	-34.14	146.07
Dividend Per Share, 3 Yr. CAGR %	9.49	27.15	23.86	11.36	-5.73
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.32	5.14	5.51	4.11	5.22
Gross Profit, 5 Yr. CAGR %	5.25	3.85	2.77	0.94	1.95
EBITDA, 5 Yr. CAGR %	12.61	22.97	16	5.84	6.09
EBITA, 5 Yr. CAGR %	13.97	26.69	18.8	4.64	6
EBIT, 5 Yr. CAGR %	13.08	26.18	19.43	4.55	5.4
Earnings From Cont. Operations, 5 Yr. CAGR %	12.91	26.04	18.02	7.55	10.13
Net Income, 5 Yr. CAGR %	8.43	19.62	13.97	9.21	12.53
Normalized Net Income, 5 Yr. CAGR %	6.68	17.54	14.33	6.38	8.54
Diluted EPS Before Extra, 5 Yr. CAGR %	8.81	20.04	14.3	9.5	12.96
Accounts Receivable, 5 Yr. CAGR %	2.86	3.88	3.7	3.11	3.64
Inventory, 5 Yr. CAGR %	7.5	12.76	9.29	9.07	10.95
Net Property, Plant and Equip., 5 Yr. CAGR %	7.09	6.15	9.11	11.6	12.1
Total Assets, 5 Yr. CAGR %	3.92	5.73	6.82	8.79	10.96
Tangible Book Value, 5 Yr. CAGR %	3.38	5.75	8.89	10.39	9.54
Common Equity, 5 Yr. CAGR %	3.77	5.97	7.04	9.06	10.66
Cash From Operations, 5 Yr. CAGR %	21.18	5.01	22.83	16.65	6.59
Capital Expenditures, 5 Yr. CAGR %	19.36	22.39	9.97	12.48	10.69
Levered Free Cash Flow, 5 Yr. CAGR %	22.57	-7.37	28.63	-5.39	69.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	21.5	-14.83	27.48	-4.86	79.54
Dividend Per Share, 5 Yr. CAGR %	13.81	23.27	18.89	10.01	9.16